cerrar
Tagged with pharmaceuticals

Interview: Frédéric Duchesne – President & CEO,…
Frédéric Duchesne, President & CEO of Pierre Fabre's pharmaceuticals division, talks about the the four main pillars at the heart of Trajectoire…

Interview: Patrick Winkler – Clinical Trial Manager &…
While functional outsourcing may be common for companies seeking services from CROs, Medpace believes that their robust, physician-led, full-service…

Interview: Olivier Laureau – President, Servier Group,…
Olivier Laureau, President of the Servier Group, discusses how Servier´s economic model is based on considerable investments in R&D to provide…

Interview: Khaled El Mounayri – Country President,…
After choosing Egypt as the first country to host a production plant in the Middle East, AstraZeneca is interested in strengthening its foothold in…

Interview: Stéphane Thiroloix – CEO, Mayoly Spindler, France
Stéphane Thiroloix, CEO of the independent and family owned Mayoly Spindler, reveals how their vision is to become a reference company…

Interview: Jean-Charles Foddis – Executive Director, Aderly…
Jean-Charles Foddis, executive director of Aderly, Lyon’s main investment agency, discusses the city’s history of economic development while…

Interview: Alain Sainsot – President, Amatsigroup, France
Amatsigroup, a Contract Development and Manufacturing Organization (CDMO), provides services throughout both preclinical and clinical phases. Leading…

Interview: Karel Fol – Country Manager Benelux, Sobi, The…
Sobi is a leading integrated biopharmaceutical company dedicated to developing innovative therapies and services to improve the lives of rare disease…

Interview: Nicolas Dupeux – Director, Disney Business Solutions…
Providing an all-in-one venue for major corporate conference, seminar, or gala events, Disney Business Solutions at Disneyland Paris provides…

Interview: Dr. Paolo Zambonardi – CEO, Ferring‬ Italy‬
Ferring Italy's CEO discusses the affiliate's successful management strategy, new products, new partnerships, and the potential of the Italian market.…

Interview: Dr. Amr Morsy – CEO, Rameda, Egypt
Five days before the January 25th revolution of 2011, Rameda changed ownership and CEO Amr Morsy set out to turn-around the mismanaged business. Five…

Interview: Francesco di Marco – General Manager, Amgen…
Francesco di Marco, General Manager for Amgen Italy, shares his view on the state of the Italian pharmaceutical sector, the turnaround the company has…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here